First drug developed by generative AI administered to patients
posted in: Breaking News, News
July 2 (UPI) — The first dose of a drug developed by artificial intelligence has been delivered to its first patient. Insilico Medicine, a biotechnology company based in Hong Kong, announced that human patients have begun receiving the drug INS018_055, … Read More